Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Co-Diagnostics
CODX
Co-Diagnostics
Decentralized Diagnostics Will Expand Global Infectious Disease Surveillance
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 1 Analyst
Published
17 Aug 25
Updated
17 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$10.00
97.1% undervalued
intrinsic discount
17 Aug
US$0.29
Loading
1Y
-79.8%
7D
14.4%
Author's Valuation
US$10.0
97.1% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$10.0
97.1% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-193m
105m
2014
2017
2020
2023
2025
2026
2028
Revenue US$65.3m
Earnings US$8.1m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
74.67%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.81%
Calculation
US$8.12m
Earnings '28
x
81.34x
PE Ratio '28
=
US$660.21m
Market Cap '28
US$660.21m
Market Cap '28
/
52.65m
No. shares '28
=
US$12.54
Share Price '28
US$12.54
Share Price '28
Discounted to 2025 @ 7.84% p.a.
=
US$10.00
Fair Value '25
